Author:
Vasco Chiara,Canazza Alessandra,Rizzo Ambra,Mossa Adele,Corsini Elena,Silvani Antonio,Fariselli Laura,Salmaggi Andrea,Ciusani Emilio
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference37 articles.
1. Wainwright DA, Nigam P, Thaci B et al (2012) Recent developments on immunotherapy for brain cancer. Expert Opin Emerg Drugs 17(2):181–202
2. Behin A, Hoang-Xuan K, Carpentier AF et al (2003) Primary brain tumors in adults. Lancet 361:323–331
3. Curtin JF, Candolfi M, Fakhouri TM et al (2008) Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS ONE 3(4):e1983
4. Crane CA, Ahn BJ, Han SJ et al (2012) Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol 14(5):584–595
5. Fujimoto S, Greene MI, Sehon AH (1976) Regulation of the immuneresponse to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol 116:800–806
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献